Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?

J Neuroimmunol. 2018 Dec 15:325:61-63. doi: 10.1016/j.jneuroim.2018.10.006. Epub 2018 Oct 19.

Abstract

Recent studies suggest a role of the autoimmune system dysregulation in Frontotemporal dementia (FTD). In the present study, we performed a broad immunological screening in a large sample of sporadic FTD patients. We reported a significant increase of antinuclear autoantibodies (ANA) positivity in 100 FTD patients as compared to 100 healthy controls (HC) (60% vs. 13%, p < .001). In FTD, ANA-positive and ANA-negative patients did not differ for any clinical feature. These data extend and further confirm autoimmune dysregulation in FTD. However, it still remains to be clarified whether these antibodies have a potential pathogenic role or represent simply an epiphenomenon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Antinuclear / blood*
  • Antibodies, Antinuclear / immunology*
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoimmunity / physiology*
  • Female
  • Frontotemporal Dementia / blood*
  • Frontotemporal Dementia / diagnosis
  • Frontotemporal Dementia / immunology*
  • Humans
  • Male
  • Middle Aged

Substances

  • Antibodies, Antinuclear
  • Autoantibodies